文献速递妇科

接受子宫切除术治疗子宫腺肌病女性的种族与民族和围手术期结局的关联

Associations between race and ethnicity and perioperative outcomes among women undergoing hysterectomy for adenomyosis.
PubMed 文献 · Fertil Steril · 2024-02-10

基于美国外科医师学会国家手术质量改进项目2012—2020年数据,12,599例子宫腺肌病子宫切除术患者中,非西班牙裔黑人或非裔美国人种族与民族与术后主要并发症风险升高独立相关(校正OR 1.54,95%CI 1.16-2.04);与白人相比,西班牙裔、非西班牙裔黑人、亚洲及夏威夷原住民或太平洋岛民种族与民族接受腹腔镜手术的可能性更低。

要点

  • 术后并发症发生率8.8%(n=1,104),主要并发症3.1%(n=385)。
  • 非西班牙裔黑人或非裔美国人种族与民族与主要并发症风险升高独立相关(校正OR 1.54,95%CI 1.16-2.04)。
  • 与白人相比,西班牙裔、非西班牙裔黑人、亚洲及夏威夷原住民或太平洋岛民接受腹腔镜的校正OR分别为0.58、0.56、0.33、0.26。

核心结论

  • 在接受子宫切除术后诊断为子宫腺肌病的女性中,非西班牙裔黑人或非裔美国人种族与民族与术后主要并发症风险升高相关。
  • 与白人相比,西班牙裔、非西班牙裔黑人或非裔美国人、亚洲及夏威夷原住民或太平洋岛民种族与民族接受微创手术的可能性更低。

研究设计与样本

  • 队列研究,数据来自美国外科医师学会国家手术质量改进项目(NSQIP)2012—2020年。
  • 研究对象为子宫腺肌病患者,干预为子宫腺肌病子宫切除术,共12,599例。
  • 患者通过国际疾病分类第9版和第10版代码617.0和N80.0(子宫子宫内膜异位症)识别,子宫切除术根据现行操作术语代码分类。
  • 比较不同种族与民族组的基线特征、手术特征及30天术后并发症,并发症按Clavien-Dindo分类系统分为次要和主要并发症。

主要发现

  • 12,599例子宫腺肌病子宫切除术女性中,非西班牙裔白人8,822例(70.0%),西班牙裔1,597例(12.7%),非西班牙裔黑人或非裔美国人1,378例(10.9%),亚洲人614例(4.9%),夏威夷原住民或太平洋岛民97例(0.8%),美洲印第安人或阿拉斯加原住民91例(0.7%)。
  • 术后并发症发生于8.8%的病例(n=1,104),其中主要并发症3.1%(n=385)。
  • 校正混杂因素后,非西班牙裔黑人或非裔美国人种族与民族与主要并发症风险升高独立相关(校正OR 1.54,95%CI 1.16-2.04)。
  • 开腹手术占13.7%(n=1,725)。
  • 与白人相比,接受腹腔镜手术的校正OR分别为:西班牙裔0.58(95%CI 0.50-0.67),非西班牙裔黑人或非裔美国人0.56(95%CI 0.48-0.65),亚洲人0.33(95%CI 0.27-0.40),夏威夷原住民或太平洋岛民0.26(95%CI 0.17-0.41)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study racial and ethnic disparities among women undergoing hysterectomy performed for adenomyosis across the United States. DESIGN: A cohort study. SETTING: Data from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) from 2012-2020. PATIENTS: Patients with an adenomyosis diagnosis. INTERVENTION: Hysterectomy for adenomyosis. MAIN OUTCOME MEASURES: Patients were identified using the International Classification of Diseases 9th and 10th editions codes 617.0 and N80.0 (endometriosis of the uterus). Hysterectomies were classified on the basis of the Current Procedural Terminology codes. We compared baseline and surgical characteristics and 30-day postoperative complications across the different racial and ethnic groups. Postoperative complications were classified into minor and major complications according to the Clavien-Dindo classification system. RESULTS: A total of 12,599 women underwent hysterectomy for adenomyosis during the study period: 8,822 (70.0%) non-Hispanic White, 1,597 (12.7%) Hispanic, 1,378 (10.9%) non-Hispanic Black or African American, 614 (4.9%) Asian, 97 (0.8%) Native Hawaiian or Pacific Islander, and 91 (0.7%) American Indian or Alaska Native. Postoperative complications occurred in 8.8% of cases (n = 1,104), including major complications in 3.1% (n = 385). After adjusting for confounders, non-Hispanic Black race and ethnicity were independently associated with an increased risk of major complications (adjusted odds ratio 1.54, 95% confidence interval [CI] {1.16-2.04}). Laparotomy was performed in 13.7% (n = 1,725) of cases. Compared with non-Hispanic White race and ethnicity, the adjusted odd ratios for undergoing laparoscopy were 0.58 (95% CI 0.50-0.67) for Hispanic, 0.56 (95% CI 0.48-0.65) for non-Hispanic Black or African American, 0.33 (95% CI 0.27-0.40) for Asian, and 0.26 (95% CI 0.17-0.41) for Native Hawaiian or Pacific Islander race and ethnicity. CONCLUSION: Among women undergoing hysterectomy for postoperatively diagnosed adenomyosis, non-Hispanic Black or African American race and ethnicity were associated with an increased risk of major postoperative complications. Compared with non-Hispanic White race and ethnicity, Hispanic ethnicity, non-Hispanic Black or African American, Asian, Native Hawaiian, or Pacific Islander race and ethnicity were less likely to undergo minimally invasive surgery.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Meyer R, Maxey C, Hamilton KM, et al. Associations between race and ethnicity and perioperative outcomes among women undergoing hysterectomy for adenomyosis. Fertil Steril. 2024. PMID: 38342374. doi:10.1016/j.fertnstert.2024.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。